Tonghua Dongbao Pharmaceutical Co Ltd (600867) — Financial Flexibility Index
Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a Financial Flexibility Index of 0.21x as of September 2025. Free cash flow of CN¥213.57 Million (operating CF CN¥62.99 Million minus capex CN¥150.58 Million) represents 0% of total liabilities (CN¥1.02 Billion). Check 600867 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tonghua Dongbao Pharmaceutical Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Tonghua Dongbao Pharmaceutical Co Ltd across 28 annual periods. See working capital position of Tonghua Dongbao Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Tonghua Dongbao Pharmaceutical Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Tonghua Dongbao Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Tonghua Dongbao Pharmaceutical Co Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.51x | CN¥1.21 Billion | CN¥689.23 Million | CN¥798.84 Million | ▲ +43.7% |
| 2024 | 1.05x | CN¥1.03 Billion | CN¥459.74 Million | CN¥978.08 Million | ▼ -51.7% |
| 2023 | 2.18x | CN¥1.21 Billion | CN¥861.52 Million | CN¥555.08 Million | ▼ -67.7% |
| 2022 | 6.75x | CN¥1.35 Billion | CN¥863.09 Million | CN¥200.74 Million | ▲ +16.6% |
| 2021 | 5.79x | CN¥1.74 Billion | CN¥1.13 Billion | CN¥299.87 Million | ▼ -15.6% |
| 2020 | 6.86x | CN¥1.67 Billion | CN¥1.19 Billion | CN¥243.80 Million | ▲ +61.8% |
| 2019 | 4.24x | CN¥1.45 Billion | CN¥1.15 Billion | CN¥341.10 Million | ▲ +87.2% |
| 2018 | 2.26x | CN¥1.65 Billion | CN¥876.94 Million | CN¥729.06 Million | ▼ -57.5% |
| 2017 | 5.33x | CN¥1.15 Billion | CN¥961.19 Million | CN¥215.30 Million | ▲ +241.8% |
| 2016 | 1.56x | CN¥1.14 Billion | CN¥725.76 Million | CN¥729.76 Million | ▲ +193.7% |
| 2015 | 0.53x | CN¥694.67 Million | CN¥294.58 Million | CN¥1.31 Billion | ▲ +35.3% |
| 2014 | 0.39x | CN¥311.97 Million | CN¥205.89 Million | CN¥795.72 Million | ▼ -35.4% |
| 2013 | 0.61x | CN¥411.41 Million | CN¥221.06 Million | CN¥678.23 Million | ▼ -45.9% |
| 2012 | 1.12x | CN¥436.15 Million | CN¥194.32 Million | CN¥388.92 Million | ▲ +894.5% |
| 2011 | 0.11x | CN¥33.76 Million | CN¥-55.07 Million | CN¥299.37 Million | ▼ -78.0% |
| 2010 | 0.51x | CN¥233.05 Million | CN¥160.40 Million | CN¥453.75 Million | ▲ +30.8% |
| 2009 | 0.39x | CN¥245.27 Million | CN¥166.20 Million | CN¥624.75 Million | ▲ +94.4% |
| 2008 | 0.20x | CN¥148.98 Million | CN¥92.31 Million | CN¥737.66 Million | ▼ -60.9% |
| 2007 | 0.52x | CN¥379.28 Million | CN¥120.94 Million | CN¥734.97 Million | ▼ -19.8% |
| 2006 | 0.64x | CN¥444.90 Million | CN¥158.00 Million | CN¥691.13 Million | ▲ +65.6% |
| 2005 | 0.39x | CN¥211.61 Million | CN¥92.23 Million | CN¥544.23 Million | ▲ +199.9% |
| 2004 | 0.13x | CN¥62.24 Million | CN¥13.17 Million | CN¥480.12 Million | ▼ -50.6% |
| 2003 | 0.26x | CN¥103.40 Million | CN¥45.51 Million | CN¥393.95 Million | ▼ -55.6% |
| 2002 | 0.59x | CN¥121.41 Million | CN¥31.99 Million | CN¥205.52 Million | ▼ -77.7% |
| 2001 | 2.65x | CN¥206.42 Million | CN¥117.73 Million | CN¥77.96 Million | ▲ +43.1% |
| 2000 | 1.85x | CN¥81.58 Million | CN¥29.12 Million | CN¥44.10 Million | ▲ +17.6% |
| 1999 | 1.57x | CN¥145.90 Million | CN¥-95.09 Million | CN¥92.79 Million | ▲ +295.9% |
| 1998 | -0.80x | CN¥-200.49 Million | CN¥-216.98 Million | CN¥249.82 Million | — |